Picture of Gland Pharma logo

GLAND Gland Pharma Income Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Annual income statement for Gland Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue20,44226,33234,62944,00736,246
Cost of Revenue
Gross Profit11,60914,97019,24722,51418,913
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses14,39817,72422,59430,00728,030
Operating Profit6,0448,60912,03414,0008,216
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes6,8639,92913,34816,18610,546
Provision for Income Taxes
Net Income After Taxes4,5197,7299,97012,1177,810
Net Income Before Extraordinary Items
Net Income4,5197,7299,97012,1177,810
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income4,5197,7299,97012,1177,810
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS28.546.56373.650.3
Dividends per Share